Unilateral oculomotor nerve palsy induced by combination therapy of interferon-alpha2b and ribavirin.
Nakamura
Akinori
A
Third Department of Medicine, Shinshu University School of Medicine, Asahi, Matsumoto.
Tojo
Kana
K
Takasu
Kaori
K
Kaneko
Kazuma
K
Komastu
Hironao
H
Ikeda
Shu-Ichi
S
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004172:Diplopia / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005133:Eye Movements / Q000187:drug effects; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D015840:Oculomotor Nerve Diseases / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin